Brimonidine 0.33% for Rosacea-Related Facial Erythema

Clinical trial NCT07431476 · COMPLETED

Trial details

NCT number: NCT07431476
Sponsor: Istanbul Training and Research Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rosacea Rosacea Subtype 1 (Erythematotelangiectatic)

Start date: 2025-05-01
Primary completion: 2025-08-07
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.